Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.

about

Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.

Item

http://www.wikidata.org/entity/Q47164528

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Radioiodine Ablation following ...... f Utility, Dose, and Toxicity.

@en

Radioiodine Ablation following ...... f Utility, Dose, and Toxicity.

@nl

type

Item

label

Radioiodine Ablation following ...... f Utility, Dose, and Toxicity.

@en

Radioiodine Ablation following ...... f Utility, Dose, and Toxicity.

@nl

prefLabel

Radioiodine Ablation following ...... f Utility, Dose, and Toxicity.

@en

Radioiodine Ablation following ...... f Utility, Dose, and Toxicity.

@nl

P1476

Radioiodine Ablation following ...... of Utility, Dose, and Toxicity

@en

P2093

Carryn M Anderson

http://www.w3.org/2001/XMLSchema#string

Hamed H Tewfik

http://www.w3.org/2001/XMLSchema#string

John M Watkins

http://www.w3.org/2001/XMLSchema#string

Nicholas S Andresen

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study.

Effects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extension.

Practice trends in patients with persistent detectable thyroglobulin and negative diagnostic radioiodine whole body scans: a survey of American Thyroid Association members.

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer.

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.

Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report.

P304

187-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000468927

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nitin A. Pagedar

John M Buatti

P577

2017-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28868259

http://www.w3.org/2001/XMLSchema#string

P932

5567113

http://www.w3.org/2001/XMLSchema#string